James Ahlers
Geen lopende functies
Vermogen: - $ op 30-04-2024
Loopbaan van James Ahlers
Eerdere bekende functies van James Ahlers
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
INTENSITY THERAPEUTICS, INC. | Corporate Officer/Principal | 01-06-2023 | 21-05-2024 |
RENOVORX, INC. | Financieel Directeur/CFO | 15-07-2022 | 05-02-2024 |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Financieel Directeur/CFO | 01-03-2002 | 01-11-2019 |
Investor Relations Contact | 01-03-2002 | 01-11-2019 | |
Public Communications Contact | 01-03-2002 | 01-11-2019 | |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Genesoft Pharmaceuticals, Inc. | Corporate Officer/Principal | - | - |
CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | - | - |
TITAN PHARMACEUTICALS, INC. | Hoofd Administratief Officier | - | - |
Financieel Directeur/CFO | - | - | |
Ansan Pharmaceuticals, Inc. | Hoofd Administratief Officier | - | - |
Financieel Directeur/CFO | - | - | |
░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Opleiding van James Ahlers
University of San Francisco | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 12 |
Operationeel
Corporate Officer/Principal | 6 |
Director of Finance/CFO | 4 |
Chief Administrative Officer | 2 |
Sectoraal
Health Technology | 8 |
Commercial Services | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
TITAN PHARMACEUTICALS, INC. | Health Technology |
CYTOKINETICS, INCORPORATED | Health Technology |
RENOVORX, INC. | Health Technology |
INTENSITY THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Health Technology |
Medco Behavioral Care Corp.
Medco Behavioral Care Corp. Pharmaceuticals: MajorHealth Technology Medco Behavioral Care Corp. specializes in behavioral health management. | Health Technology |
Ansan Pharmaceuticals, Inc. | Health Technology |
Genesoft Pharmaceuticals, Inc. | Commercial Services |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
- Beurs
- Insiders
- James Ahlers
- Ervaring